Molecular Health Licenses SafetyMAP(TM) to the U.S. Food and Drug Administration (FDA)

CAMBRIDGE, Mass., Sept. 9, 2015 (GLOBE NEWSWIRE) -- Molecular Health has entered into a commercial license to provide the FDA with use of its SafetyMAP(TM) software - formally known as Molecular Analysis of Side Effect information (MASE(TM)), to provide a comprehensive and dynamic analytical solution for the detection and molecular analysis of drug-induced adverse events for all marketed drugs and for predicting safety issues of new drug candidates...

New York, 09/09/2015 (informazione.news - comunicati stampa - varie)
Copyright GlobeNewswire


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: %s via Globenewswire